Correlation Between Vanguard Mid and Innovator IBD

Can any of the company-specific risk be diversified away by investing in both Vanguard Mid and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard Mid and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vanguard Mid Cap Growth and Innovator IBD 50, you can compare the effects of market volatilities on Vanguard Mid and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard Mid with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard Mid and Innovator IBD.

Diversification Opportunities for Vanguard Mid and Innovator IBD

0.9

Correlation Coefficient

Vanguard Mid  Innovator IBD

Almost no diversification

The 3 months correlation between Vanguard and Innovator is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard Mid Cap Growth and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and Vanguard Mid is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard Mid Cap Growth are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of Vanguard Mid i.e., Vanguard Mid and Innovator IBD go up and down completely randomly.

Pair Corralation between Vanguard Mid and Innovator IBD

Considering the 90-day investment horizon Vanguard Mid Cap Growth is expected to generate 0.5 times more return on investment than Innovator IBD. However, Vanguard Mid Cap Growth is 2.0 times less risky than Innovator IBD. It trades about -0.05 of its potential returns per unit of risk. Innovator IBD 50 is currently generating about -0.03 per unit of risk. If you would invest  25,463  in Vanguard Mid Cap Growth on December 30, 2024 and sell it today you would lose (1,052) from holding Vanguard Mid Cap Growth or give up 4.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Vanguard Mid Cap Growth  vs.  Innovator IBD 50

Vanguard Mid Cap

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vanguard Mid Cap Growth has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vanguard Mid is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Innovator IBD 50

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innovator IBD 50 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Innovator IBD is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Vanguard Mid and Innovator IBD

The main advantage of trading using opposite Vanguard Mid and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard Mid position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.

The idea behind Vanguard Mid Cap Growth and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.